"Viral Matrix Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.
| Descriptor ID |
D014763
|
| MeSH Number(s) |
D12.776.964.970.880.940
|
| Concept/Terms |
Viral Matrix Proteins- Viral Matrix Proteins
- Matrix Proteins, Viral
- Proteins, Viral Matrix
- Membrane Proteins, Viral
- Viral M Proteins
- M Proteins, Viral
- Proteins, Viral M
- Viral Membrane Proteins
- Proteins, Viral Membrane
|
Below are MeSH descriptors whose meaning is more general than "Viral Matrix Proteins".
Below are MeSH descriptors whose meaning is more specific than "Viral Matrix Proteins".
This graph shows the total number of publications written about "Viral Matrix Proteins" by people in this website by year, and whether "Viral Matrix Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viral Matrix Proteins" by people in Profiles.
-
Philosophy of voltage-gated proton channels. J R Soc Interface. 2014 Mar 06; 11(92):20130799.
-
Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease. Neurosurgery. 2009 Apr; 64(4):602-12; discussion 612-3.
-
VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples. BMC Immunol. 2006 May 25; 7:11.
-
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. J Natl Cancer Inst. 2004 Oct 06; 96(19):1447-57.